Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
0.4313
+0.0048 (1.13%)
At close: Mar 28, 2025, 4:00 PM
0.3493
-0.0820 (-19.01%)
Pre-market: Mar 31, 2025, 8:39 AM EDT
Enzo Biochem Employees
As of July 31, 2024, Enzo Biochem had 136 total employees, including 125 full-time and 11 part-time employees. The number of employees decreased by 54 or -28.42% compared to the previous year.
Employees
136
Change (1Y)
-54
Growth (1Y)
-28.42%
Revenue / Employee
$213,926
Profits / Employee
-$156,706
Market Cap
22.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ENZ News
- 2 days ago - Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - GlobeNewsWire
- 13 days ago - Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewsWire
- 2 months ago - Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - GlobeNewsWire
- 3 months ago - Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update - GlobeNewsWire
- 5 months ago - Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend - GlobeNewsWire
- 8 months ago - Enzo Biochem to pay $4.5 mln for failing to safeguard patient data - Reuters
- 9 months ago - Enzo Biochem: Is This Time Finally Different? - Seeking Alpha
- 10 months ago - Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire